2025-21301Notice

AstraZeneca Gets Special Manufacturing Deal in Indiana Trade Zone

Published Date: 11/26/2025

Notice

Summary

AstraZeneca’s Mount Vernon plant got the green light to do some limited drug production inside Foreign-Trade Zone 177 for the next three years. They must prove after two years that their imported ingredients come from safe, trusted countries. This move helps AstraZeneca keep costs down while following strict safety rules.

No Economic Impacts Identified for this Document

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Effective Date
Published Date
11/14/2025
11/26/2025

Department and Agencies

Department
Independent Agency
Agency
Commerce Department
Foreign-Trade Zones Board
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register